Login / Signup

Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study.

Mikkel HojlundLars Christian LundJonas Leander Emming HerpingMaija Bruun HaastrupPer DamkierDaniel Pilsgaard Henriksen
Published in: BMJ open (2020)
Use of SGA is associated with a small-to-moderately increased risk of incident CKD. All investigated SGAs, except for aripiprazole, were associated with an increased risk of CKD.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • cardiovascular disease